Clinical Trials Directory

Trials / Completed

CompletedNCT01696708

Utilization of 31P-Nuclear Magnetic Resonance Spectroscopy to Monitor Brain Energy Deficit in Huntington Disease

Study of the Brain Energy Profile Evolution, Using 31Phosphorus-Nuclear Magnetic Resonance Spectroscopy, at Different Stages of Huntington Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this project is to study brain energy profile evolution at different stages of the Huntington disease.

Conditions

Interventions

TypeNameDescription
OTHER31-Phosphorus RMN Spectroscopy

Timeline

Start date
2012-12-06
Primary completion
2015-11-01
Completion
2015-11-01
First posted
2012-10-01
Last updated
2025-12-10

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01696708. Inclusion in this directory is not an endorsement.